Legal & General Group
CLPT icon

Legal & General Group’s ClearPoint Neuro CLPT Stock Holding History

Legal & General Group’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.6K Sell
2,372
-412
-15% -$5.2K ﹤0.01% 2939
2025
Q4 		$38.1K Sell
2,784
-118
-4% -$2.19K ﹤0.01% 2801
2025
Q3 		$63.2K Hold
2,902
– – ﹤0.01% 2688
2025
Q2 		$34.6K Buy
+2,902
New +$36.5K ﹤0.01% 2799
2024
Q2 		– Sell
-2,261
Closed -$15.4K – 3436
2024
Q1 		$15.4K Sell
2,261
-139
-6% -$971 ﹤0.01% 3074
2023
Q4 		$16.3K Sell
2,400
-321
-12% -$1.82K ﹤0.01% 3113
2023
Q3 		$13.6K Hold
2,721
– – ﹤0.01% 3180
2023
Q2 		$19.7K Buy
+2,721
New +$23.1K ﹤0.01% 3118
2022
Q2 		– Sell
-1,991
Closed -$21K – 3548
2022
Q1 		$21K Hold
1,991
– – ﹤0.01% 3228
2021
Q4 		$22K Hold
1,991
– – ﹤0.01% 3242
2021
Q3 		$35K Hold
1,991
– – ﹤0.01% 3076
2021
Q2 		$38K Buy
+1,991
New +$38.5K ﹤0.01% 3040

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Legal & General Group's CLPT Position: Q1 2026 in Review

Legal & General Group reduced its ClearPoint Neuro (CLPT) stake by 15% in Q1 2026, selling an estimated $5.2K and leaving 2,372 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2939.

Legal & General Group first reported a position in CLPT in Q2 2021 and has held it in 12 quarters since. The position peaked at $63.2K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Legal & General Group held 2,372 shares of ClearPoint Neuro worth $21.6K as of Q1 2026.
  • Legal & General Group sold 412 ClearPoint Neuro shares in Q1 2026, an estimated $5.2K.
  • ClearPoint Neuro made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2939 holding.
  • Legal & General Group first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 12 quarters since.
  • Legal & General Group's ClearPoint Neuro position peaked at $63.2K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.